surpass 5 tirzepatide Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial Read now: The SURPASS-EARLY trial
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



00157-3/asset/c84fcc65-a3a1-494b-a6da-4db36d90d167/main.assets/gr1_lrg.jpg)





















